U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378306) titled 'FMD and Neoadjuvant Chemo-immunotherapy in TNBC' on Jan. 16.
Brief Summary: The primary objective of this study is to investigate the efficacy and safety of a fasting-mimicking diet (FMD) intervention combined with standard neoadjuvant chemoimmunotherapy in early-stage or locally advanced triple-negative breast cancer (TNBC).
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
OTHER: Fasting-mimicking diet
The Fasting-Mimicking Diet (FMD) will be administered every three weeks for a maximum of 8 consecutive cycles, unless side effects necessitate its temporary or permanent discontinuati...